SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-21-004766
Filing Date
2021-05-17
Accepted
2021-05-17 18:44:44
Documents
2
Period of Report
2021-05-17

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1547
2 exhibit24.txt EX-24 2938
  Complete submission text file 0001062993-21-004766.txt   6101
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EMERALD BIOSCIENCE, INC. 130 NORTH MARINA DRIVE LONG BEACH CA 90803
Business Address
KIM DENNIS D (Reporting) CIK: 0001456750 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36500 | Film No.: 21933124